✦ LIBER ✦

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

✍ Scribed by Gopal, S.; Vijapurkar, U.; Lim, P.; Morozova, M.; Eerdekens, M.; Hough, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

334 – Long-term safety/tolerability of p

✍ M. Kramer; G. Simpson; S. Kushner; Y. Liu; P. Lim; D. Hough; M. Eerdekens; J. Pa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

322 – Efficacy/tolerability of paliperid

✍ M. Kramer; R. Litman; R. Lane; M. Kujawa; P. Lim; D. Hough; M. Eerdekens 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 76 KB

P.3.d.004 A 57-week, open-label evaluati

✍ Wakamatsu, A.; Takahashi, N.; Takahashi, M.; Saito, T.; Iizumi, M.; Imai, Y.; Sa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

1096 – Safety, tolerability and treatmen

✍ Schreiner, A.; Hargarter, L.; Bergmans, P.; Cherubin, P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 43 KB

A one-year prospective study of the safe

✍ Danielle Coppola, Yanning Liu, Srihari Gopal, Bart Remmerie… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 396 KB

P.3.d.014 Efficacy and safety of paliper

✍ Wakamatsu, A.; Takahashi, N.; Takahashi, M.; Saito, T.; Iizumi, M.; Saito, Y.; S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB